psychotic-disorders

Documents about psychotic-disorders

• Family Intervention for Mental Illness and Substance Abuse#910416ClinicalTrials.gov
• The Association Between Trajectories of Self-reported Psychotic Experiences and Continuity of Mental Health Care in a Longitudinal Cohort of Adolescents and Young Adults#246769HAL (France)
• A Study of the Effectiveness and Safety of Risperidone Compared With Haloperidol and Placebo in Patients With Chronic Schizophrenia#813086ClinicalTrials.gov
• Psychiatric Genotype/Phenotype Project Repository#859472ClinicalTrials.gov
• Public Health Service Clinical Journeys of Patients With Primary Substance Use Disorders Who Are Subsequently Diagnosed With Non-Affective Psychotic Disorders.#323087NCBI PubMed Central
• Sarcosine or D-Serine Add-on Treatment for Chronic Schizophrenia#981342ClinicalTrials.gov
• Turkish adaptation study of the Metacognition Assessment Scale-Abbreviated in psychotic disorders.#685500NCBI PubMed Central
• Resting State Electroencephalogram for Psychotic Disorders#807452ClinicalTrials.gov
• Impact of Case-management on Therapeutic Alliance With First Episode Psychosis Patients (CAMAT)#885411ClinicalTrials.gov
• Aspirin in Young Psychotic Patients#906208ClinicalTrials.gov
• PACT for Individuals With Serious Mental Illness#840314ClinicalTrials.gov
• Factors associated with infection-related hospitalisations in severe mental illness: a retrospective cohort study#624450Europe PMC
• Partners in Wellness: Evaluation of a Pay for Performance Program for High-Utilizers of Mental Health Services#825301ClinicalTrials.gov
• A Trial of 15 and 30 mg Doses of CVL-231 (Emraclidine) in Participants With Schizophrenia#884031ClinicalTrials.gov
• Supporting Patients by Family Education in Psychotic Illness: A Prospective Cohort Study#909838ClinicalTrials.gov
• Weight Management Program for Patients With First Episode Psychosis#152532ClinicalTrials.gov
• Feasibility Trial of CBT for Depersonalisation in Psychosis#913650ClinicalTrials.gov
• Facilitating Engagement in Evidence-Based Treatment for Early Psychosis#980194ClinicalTrials.gov
• Evaluation of the Necessity of Long-term Pharmacological Treatment With Antipsychotics in Schizophrenic Patients#1010260ClinicalTrials.gov
• Emotion recognition misclassification patterns in individuals with psychotic spectrum disorders and history of interpersonal aggression.#315434NCBI PubMed Central
• Development and Pilot Evaluation of Modified Cognitive Behavioural Therapy for Adolescents With Early Onset Psychosis#917846ClinicalTrials.gov
• Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)#829036ClinicalTrials.gov
• CBT-I for Psychosis: Guidelines, Preliminary Efficacy, and Functional Outcomes#890684ClinicalTrials.gov
• Comparison of Clozapine vs Olanzapine in Childhood-Onset Psychotic Disorders#803501ClinicalTrials.gov
• The proportion of people with primary affective disorders presenting to early intervention services: systematic review and meta-analysis#221999Spiral
• Differential Risk of Death in Older Residents in Nursing Homes Prescribed Specific Antipsychotic Drugs: Population Based Cohort Study#485730Harvard DASH
• Minnesota Community-Based Cognitive Training in Early Psychosis#845596ClinicalTrials.gov
• New Drugs in the Treatment of Mood Disorders#807682ClinicalTrials.gov
• Cultural Adaptation of Group CBT Psychosis Manual and Establishing Its Efficacy in Pakistan#811981ClinicalTrials.gov
• A Novel Peer-Delivered Recovery-Focused Suicide Prevention Intervention for Veterans With Serious Mental Illness#858712ClinicalTrials.gov
• Psychological Interventions Targeting Auditory Hallucinations in Persons With Psychotic Disorders: A Systematic Review and Meta-Analysis.#295065NCBI PubMed Central
• Emotion recognition misclassification patterns in individuals with psychotic spectrum disorders and history of interpersonal aggression#314757Europe PMC
• In people with ultra high risk symptoms, risk of transition to psychotic disorders is highest in the first 2 years#409754PubMed Central
• Racial Disparities in the Expression of Paranoia#884493ClinicalTrials.gov
• ED to EPI: Using SMS to Improve the Transition From the Emergency Department to Early Psychosis Intervention#854382ClinicalTrials.gov
• Exploring attachment, trauma, and cannabis use in psychotic disorders: a qualitative study of patient and family perspectives.#159702NCBI PubMed Central
• Safety behaviors maintain persecutory ideation in individuals with psychotic disorders: evidence from an ecological momentary assessment study.#262859NCBI PubMed Central
• Family-Level Brain Pattern Similarities and Their Clinical Significance in Young Offspring of Individuals With Psychotic Disorders.#406400NCBI PubMed Central
• Glucose as a Mediator of Self-control Performances in Patients With Schizophrenia#883013ClinicalTrials.gov
• Serial Comparisons of Abdominal and Neurological MRI Scans#911611ClinicalTrials.gov
• Effect of AQW051 on Cognitive Function in Patients With Chronic Stable Schizophrenia#968475ClinicalTrials.gov
• Effects of an Acceptance-based Medication Adherence Therapy for Recent-onset Psychosis#855272ClinicalTrials.gov
• Social affective forecasting and the default mode network in schizophrenia spectrum disorders: A daily diary and fMRI study#15860OSF
• Adverse Childhood Experiences and Personal Recovery in Individuals with Schizophrenia Spectrum Disorders: Results from a longitudinal cohort#397193OSF
• Safety and Efficacy of Virtual Reality Mindfulness in Patients With Psychosis#890057ClinicalTrials.gov
• Cognitive Control Neural Correlates of Negative Affective in Psychosis Spectrum Disorders: A Laboratory and Ecological Momentary Assessment Study#1040291OSF
• Dose reduction and discontinuation of antipsychotics in psychotic disorders: a systematic review of qualitative studies and meta-synthesis.#3841NCBI PubMed Central
• The Coherence Problem: Integrating Computational, Phenomenological, and Network Accounts of Psychopathological Transformation#120247OSF
• Screening for Cognitive Decline in Psychotic Disorders in Midlife: Examining Scoring the Clinical Dementia Rating Using Longitudinal Data.#247515NCBI PubMed Central
• Associations among subjective cognitive complaints, perceived social support, and medication adherence in patients with psychotic disorders.#653267NCBI PubMed Central